TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | 1 | -2 | -4 | 12 | 14 | 3 | 4 |
| S | %wins | 33 | 67 | 67 | 0 | 0 | 33 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/29/07 19:00 | 1/5/07 | PDLI | Pdl Biopharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Calcott Peter H | CA | O | VP,Quali | S | -14 | 20.47 | 24 | -1 | -26 | 2 | D | 10 | -26 | 16 | 2 | -5 | 4 | -3 | -2 | 1 | -1 | -8 | 24 | 15 | -30 |
10/12/06 12:50 | 10/10/06 | PDLI | Pdl Biopharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Calcott Peter H | CA | O | VP,Quali | S | -13 | 20.34 | 22 | -1 | -25 | 2 | D | 8 | -26 | -32 | 16 | 2 | 10 | 6 | 0 | 2 | 1 | 3 | 6 | 20 | 13 |
7/7/06 15:31 | 7/5/06 | PDLI | Pdl Biopharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Calcott Peter H | CA | O | VP,Quali | S | -8 | 18.44 | 32 | 0 | -15 | 3 | D | -1 | -9 | -38 | -43 | -4 | 3 | 7 | 1 | 0 | -7 | -6 | 6 | 8 | 26 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |